Eli Lilly signs CSO Daniel Skovronsky to $5M non-compete clause

Eli Lilly announced Friday afternoon that it has signed a $5 million non-competition agreement with Daniel Skovronsky, EVP, chief scientific and medical officer, and president, Lilly Research Laboratories.